Biocartis Group NV: Biocartis kondigt CE-IVD markering van zijn Idylla(TM) MSI Test aan

NEXT STORY
Capital Senior Living Corporation Reports Fourth Quarter and Full Year 2018 Results; Announces Changes to Senior Leadership
PREV STORY
Terveystalo Plc: Report by the Board of Directors, Financial Statements and Corporate Governance Statement 2018 published
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Turning Point Therapeutics Initiates Global Phase 1/2 Forge-1 Clinical Study of TPX-0131, a Next-Generation ALK Inhibitor

author_avatar
NASDAQ Market News

EBS EQUITY ALERT: Kessler Topaz Meltzer & Check, LLP Announces that a Securities Fraud Class Action Lawsuit was filed on Behalf of Investors of Emergent BioSolutions Inc.

author_avatar
NASDAQ Market News

Signature Resources Announces $1.42 Million Flow Through Deal Backstopped by Crescat Capital LLP

author_avatar
NASDAQ Market News